Wednesday, February 10, 2010, 12:11am EST - Canadian Markets open in 9 hours and 19 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Abaxis Inc. (ABAX)

 On Feb 9: 23.23 USD  Up 0.23 (1.00%)  
MORE ON ABAX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ABAXIS, Inc. (NasdaqNM:ABAX) Delayed quote dataEdit
After Hours: 23.00 Down 0.23 (0.99%) as of 5:00pm EST on 02/09/10
Last Trade: 23.23 USD
Trade Time: Feb 9
Change: Up 0.23 (1.00%)
Prev Close: 23.00
Open: 23.02
Bid: 22.37 x 100
Ask: 23.83 x 100
1y Target Est: 27.25
Day's Range: 22.91 - 23.28
52wk Range: 13.54 - 29.80
Volume: 123,030
Avg Vol (3m): 135,778
Market Cap: 511.85M
P/E (ttm): 40.26
EPS (ttm): 0.58
Div & Yield: N/A (N/A%)
Abaxis Inc. (ABAX)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add ABAX to Portfolio   Download Data

HEADLINES
• Abaxis Misses Zacks Estimate
Zacks.com (Mon, Feb 1)
• New Star Analyst Rankings for ABAXIS, Inc.
StarMine (Sat, Jan 30)
• [$$] Russell 2000 Closes Out January With a Decline of 1%
at The Wall Street Journal Online (Fri, Jan 29)
• ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Jan 28)
• Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010
PRNewswire (Thu, Jan 28)
• Abaxis to Report Third Quarter Fiscal 2010 Financial Results Thursday, January 28, 2010
PRNewswire (Thu, Jan 28)
• Q3 2010 Abaxis, Inc. Earnings Release - Time Not Supplied
CCBN (Thu, Jan 28)
• Abaxis Receives Approval
Zacks.com (Fri, Jan 22)
• Abaxis says FDA clears new infection test
AP (Thu, Jan 21)
• FDA clears Abaxis health-care testing product
at bizjournals.com (Thu, Jan 21)
• Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
PRNewswire (Thu, Jan 21)
• Abaxis to Report Third Quarter Fiscal 2010 Financial Results Thursday, January 28, 2010
PRNewswire (Wed, Jan 20)
More Headlines for ABAX...
ANALYST
EPS Est (next year) (Mar-10) : 0.64
EPS Est (in 2 years) (Mar-11) : 0.86
Avg Rec (current)*: 2.5
PEG Ratio: 1.60
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements in the medical and veterinarian markets...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices